Milk Thistle vs Placebo: What Controlled Trials Show (2026)
What placebo-controlled milk thistle trials show, in liver disease and outside it, and how to read genuinely mixed results without overstating them.
What placebo-controlled milk thistle trials show, in liver disease and outside it, and how to read genuinely mixed results without overstating them.
What human milk thistle trials measured: liver disease populations, trial design and duration, diabetes research, and what systematic reviews conclude.
How milk thistle is thought to work: the active silymarin compounds, antioxidant and membrane effects, and the limits of current understanding.
Explore the differences between silymarin and silybin, the key flavonolignans in milk thistle, including composition, bioavailability, and supplement standardiz
Compare silymarin phytosome and standard milk thistle extracts. Learn about absorption mechanisms, bioavailability technology, and what current evidence suggest
Evidence-based review of intravenous silymarin (Legalon® SIL) as emergency antidote for amatoxin mushroom poisoning, mechanisms, timing, and clinical outcomes.
Evidence review of silymarin’s antifibrotic mechanisms and human trial data in NAFLD, NASH, and HCV-related liver fibrosis.
Explore how novel delivery systems like cyclodextrin complexes, nanoparticles, and molecular salts aim to overcome silymarin’s poor oral bioavailability compare
Explore how silymarin activates the Nrf2 pathway to combat oxidative stress, with evidence from preclinical studies on liver, kidney, and neural protection.
An evidence-based review of silymarin (milk thistle) for alcoholic liver disease, covering mechanisms, clinical trial data, and systematic review findings.
Compare milk thistle (silymarin) and TUDCA mechanisms, uses, and evidence for liver health. Understand differences between flavonoid and bile acid approaches.
Compare milk thistle supplement forms — capsules, liquid extracts, powders, and teas — for silymarin delivery, absorption, and practical use.